chr9-37762069-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144964.4(TRMT10B):āc.138G>Cā(p.Glu46Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,614,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_144964.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRMT10B | NM_144964.4 | c.138G>C | p.Glu46Asp | missense_variant | 2/9 | ENST00000297994.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRMT10B | ENST00000297994.4 | c.138G>C | p.Glu46Asp | missense_variant | 2/9 | 1 | NM_144964.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000406 AC: 101AN: 249066Hom.: 0 AF XY: 0.000370 AC XY: 50AN XY: 135132
GnomAD4 exome AF: 0.000138 AC: 201AN: 1461806Hom.: 0 Cov.: 31 AF XY: 0.000149 AC XY: 108AN XY: 727198
GnomAD4 genome AF: 0.000203 AC: 31AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2021 | The c.138G>C (p.E46D) alteration is located in exon 2 (coding exon 1) of the TRMT10B gene. This alteration results from a G to C substitution at nucleotide position 138, causing the glutamic acid (E) at amino acid position 46 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at